Cytek Biosciences Patent Win: What Three Favourable Claims Mean for CTKB Stock
Cytek Biosciences secured a significant legal victory, winning three of four patent claims in a closely watched intellectual property dispute. The partial win removes a major overhang from CTKB shares and reshapes the competitive landscape in full-spectrum flow cytometry.